levocarnitine with tirzepatide L-Carnitine tirzepatide levocarnitine compound Compounded GLP-1/GIP

PKA and Epac-2 trigger the closure of KATP and KV channels, which depolarizes the cell membrane, opens voltage-dependent calcium channels (VDCC), and causes Ca2+ influx

But don't worry, the story of how GLP-1 was made into a viable drug is so interesting it's almost worthy of its own article

PMCID: PMC7594204

They believed it differed from pancreozymin, another small intestine hormone identified by Ivy in 1928 that was subsequently renamed cholecystokinin (CCK) (Kosaka, Lim)

The ability of semaglutide, a GLP-1 receptor agonist, to reduce heavy drinking in individuals with obesity and alcohol use disorder adds to the growing literature on gut-brain axis modulation of addictive behaviors

This can land folks who switch plans in a tight spot